Liesbet De Bus

10PUBLICATIONS
47CO-AUTHORS
Medical bacteriologyMedical infection agents (incl. prions)Human impacts of climate change and human adaptationMajor global burdens of diseaseRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 25, 2025
Impact of reporting rapid susceptibility results in Gram negative bloodstream infections: a real world prospective study.

Anne-Sophie Messiaen, Stien Vandendriessche, Emilie De Muynck

|May 13, 2024
Empirical antimicrobials in the intensive care unit.

Liesbet De Bus, Kostoula Arvaniti, Fredrik Sjövall

|Sep 28, 2023
When fear takes control: the multidrug resistance story during pandemics.

Marc Leone, Liesbet de Bus, Andrew Conway Morris

|Apr 29, 2023
Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study.

Thomas De Corte, Jarne Verhaeghe, Sofie Dhaese

|Feb 10, 2023
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study.

Alexis Tabah, Niccolò Buetti, Quentin Staiquly

|Oct 28, 2021
Antimicrobial prescription in severe COVID-19 and CAP: a matched case-control study.

J Fierens, L De Bus, K Colpaert

Pageof 2

Frequent Collaborators

4 joint publications

Jan J De Waele

4 joint publications

Pieter Depuydt

2 joint publications

Jerina Boelens

2 joint publications

Bram Gadeyne